UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

March 31, 2013

Date of Report: (Date of earliest event reported)

 

Cyanotech Corporation

(Exact name of registrant as specified in its charter)

 

NEVADA

(State or other jurisdiction of
incorporation)

 

000-14602

(Commission File Number)

 

91-1206026

(IRS Employer Identification
Number)

 

73-4460 Queen Kaahumanu Highway, Suite #102, Kailua Kona, HI 96740

(Address of principal executive offices)

 

(808) 326-1353

(Registrant’s telephone number)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 8.01  Other Events.

 

Throughout Fiscal 2013, the Company had included in its SEC Forms 10-Q for the first three quarters certain information on Net Sales by Product.  Similar information on Fourth Quarter results was not included in the Company’s SEC Form 10-K for Fiscal 2013, ended March 31, 2013, which was filed on June 24, 2013.  The Company believes that such information may be of interest to its stockholders, other investors and other interested persons and is therefore providing the following information for the periods indicated ($ in thousands):

 

 

 

Three Months Ended

 

Twelve Months Ended

 

 

 

March 31, 2013

 

March 31, 2012

 

March 31, 2013

 

March 31, 2012

 

Net sales by product

 

 

 

 

 

 

 

 

 

Bulk sales

 

 

 

 

 

 

 

 

 

Spirulina bulk

 

$

960

 

$

1,029

 

$

3,600

 

$

4,984

 

Spirulina bulk sales decrease

 

(6.7

)%

 

 

(27.7

)%

 

 

Astaxanthin bulk

 

$

2,342

 

$

2,689

 

$

11,604

 

$

11,121

 

Astaxanthin bulk sales increase

 

(12.9

)%

 

 

4.3

%

 

 

Total Bulk sales

 

$

3,302

 

$

3,718

 

$

15,204

 

$

16,123

 

Total Bulk sales decrease

 

(11.2

)%

 

 

(5.7

)%

 

 

 

 

 

 

 

 

 

 

 

 

Packaged sales

 

 

 

 

 

 

 

 

 

Spirulina packaged

 

$

1,641

 

$

1,019

 

$

5,263

 

$

3,717

 

Spirulina packaged sales increase

 

61.0

%

 

 

41.6

%

 

 

Astaxanthin packaged

 

$

1,954

 

$

1,249

 

$

7,109

 

$

4,791

 

Astaxanthin packaged sales increase

 

56.4

%

 

 

48.4

%

 

 

Total Packaged sales

 

$

3,595

 

$

2,268

 

$

12,372

 

$

8,508

 

Total Packaged sales increase

 

58.5

%

 

 

45.4

%

 

 

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

CYANOTECH CORPORATION

 

 

 

 

Dated: June 26, 2013

/s/ Jolé Deal

 

By:

Jolé Deal

 

 

Vice President — Finance and

 

 

Administration, Chief Financial

 

 

Officer, Treasurer and Secretary

 

3